Astrocyte Pharmaceuticals secures $9.5M Series B funding to advance AST-004 into Phase II trials for concussion and TBI ...

Foghorn Therapeutics is cutting about 40% of its workforce after ending FHD-909 and other SMARCA2 programs with Lilly. Read ...

Atara Biotherapeutics resubmits tabelecleucel BLA to FDA for EBV+ post-transplant lymphoproliferative disease. Latest updates ...

Progentos begins Phase I/II human trial of oral PRO-1562 for multiple sclerosis remyelination. First-in-human study ...

CMS finalized the mandatory GLOBE model, linking Medicare Part B rebates to international drug prices starting in 2027. See ...

Regeneron and Sanofi expand antibody alliance with $1B upfront and $7B in milestones for IL-4/IL-13 pathway treatments. Learn ...

NRx Pharmaceuticals wins $11.2M DARPA funding to test NRX-101 combined with robotic TMS for treatment-resistant depression.

Eli Lilly's retatrutide shows 20.8% weight loss and A1C improvements in type 2 diabetes. TRIUMPH-2 trial results presented at ...

AbbVie's amylin analog ABBV-295 achieves every-other-week dosing with significant weight loss in Phase I obesity trial. Full ...

Varda Space Industries secures $251M Series D funding to scale space-based pharmaceutical manufacturing. Learn how orbital ...

Immix Biopharma secures $125 million funding to advance NXC-201 CAR-T therapy for amyloidosis treatment. Learn about this ...

Roche's fenebrutinib receives FDA priority review for relapsing and primary progressive MS. First BTK inhibitor filing for ...